Aortic stiffness in vivo in hypertensive rat via echo-tracking: analysis of the pulsatile distension waveform

• Published in: American journal of physiology. Heart and circulatory physiology 2011-08, Vol.301 (2), p.H382-H390
• Main Authors: Vayssettes-Courchay, Christine, Ragonnet, Christophe, Isabelle, Marc, Verbeuren, Tony J
• Format: Article
• Language: English
• Subjects: Aging; Analysis of Variance; Animals; Antihypertensive Agents - pharmacology; Aorta - diagnostic imaging; Aorta - drug effects; Aorta - metabolism; Aorta - physiopathology; Blood Pressure - drug effects; Calcium Channel Blockers - pharmacology; Compliance; Diltiazem - pharmacology; Disease Models, Animal; Enzyme Inhibitors - pharmacology; Hypertension; Hypertension - diagnostic imaging; Hypertension - drug therapy; Hypertension - metabolism; Hypertension - physiopathology; Male; NG-Nitroarginine Methyl Ester - pharmacology; Nitric oxide; Nitric Oxide - metabolism; Nitric Oxide Synthase - antagonists & inhibitors; Nitric Oxide Synthase - metabolism; Pulsatile Flow - drug effects; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Risk factors; Rodents; Signal Processing, Computer-Assisted; Time Factors; Ultrasonography; Veins & arteries
• ISSN: 0363-6135; 1522-1539
• DOI: 10.1152/ajpheart.00094.2011

Large-artery stiffening is a major risk factor in aging and hypertension. Elevated blood pressure (BP) and vascular wall properties participate in arterial stiffening; we aimed to evaluate their respective role by combining echo-tracking and the spontaneously hypertensive rats (SHR) treated with low doses of a nitric oxide synthase inhibitor, shown to have arterial stiffening. Normotensive [Wistar-Kyoto (WKY)], SHR, and SHR treated for 2 wk with N(G)-nitro-L-arginine methyl ester (SHRLN) were anesthetized; BP and distension (pulsatile displacement) of the aortic walls with the ArtLab echo-tracking device were measured. Stiffness index increased in SHRLN vs. SHR; compliance, distensibility, and the slopes and area of the distension-pressure loop curve decreased. The pulsatile distension and pressure waveforms were strongly altered in SHRLN. Maximal values were decreased and increased, respectively, and the waveform kinetics also differed. Thus the area under the curve adjusted to heart rate (AUC/ms) was calculated. Acute BP reductions were induced by diltiazem in SHR and SHRLN, to levels similar to those of WKY. In SHR, compliance, distensibility, stiffness index, and the ascending slope of the distension-pressure loop reached the values of WKY, whereas they were only partially improved in SHRLN. Aortic distension (maximal value and AUC/ms) and the area of the distension-pressure loop were improved in SHR, but not in SHRLN. These data confirm the aortic stiffening induced by nitric oxide reduction in SHR. They show that the ArtLab system analyzes aortic stiffness in rats, and that the aortic pulsatile distension waveform is a parameter strongly dependent on the vascular wall properties.